CN Bio

Did you catch CN BioSenior scientists, Dr. Morné van Wyk and Dr. Marco Ortiz discuss the science behind our latest publication in Drug Metabolism and Disposition - A primary human Gut/Liver microphysiological system to estimate human oral bioavailability? If you missed the live event, you can now watch the presentation on demand 👉 MPS and In Silico Modeling: The next generation of bioavailability prediction 🔗https://lnkd.in/e3ujgGBT

We're looking for a Research Assistant to join our Biology team and support contract research projects. 🧬 Are you passionate about cutting-edge biological research and ready to make an impact in a dynamic lab environment? What you'll be doing: - Culturing cell lines and primary cells to maintain healthy stocks - Preparing and running organ-on-a-chip experiments using the CN Bio PhysioMimix system - Performing a range of biological assays including ELISAs, microscopy, DNA/RNA extractions, and qPCR - Analyzing data and producing high-quality internal reports If you're detail-oriented, proactive, and excited by innovative science, we’d love to hear from you! 💡 More details about the role and how to apply here: https://lnkd.in/epu9kHmZ

🚀 Introducing The PhysioMimix® Core microphysiological system – Your universal end-to-end Organ-on-a-chip solution! Launched today, it's the only microphysiological system on the market with validated performance across single-organ, multi-organ, and high-throughput configurations. PhysioMimix Core makes Organ-on-a-chip easy to: ✔ Adopt – Start simple for immediate productivity ✔ Adapt – Flexibility to grow with your research needs ✔ Scale – To match immediate and future demand With unrivaled simplicity, flexibility, and scalability, the new PhysioMimix Core mimics physiology like no other for future-proofed Organ-on-a-Chip research. 👉 Learn more: https://bit.ly/3KFMSQO 👉 Explore the features and benefits: https://bit.ly/4nRRJwW #PhysioMimixCore #OrganOnAChip #LikeNoOther #EasyToAdopt #EasytoAdapt #EasyToScale

The consensus was clear at the WC13 Rio - World Congress on Alternatives and Animal Use in the Life Sciences, the adoption of NAMs and MPS is no longer a question of "if," but rather "how fast." Read this blog with insights from our CSO, Dr. Tomasz Kostrzewski first visit to the conference.

In a recent feature with Business Focus Magazine, our CEO, Dr. Paul Brooks shares his vision for CN Bio's growth and the strategic direction under his leadership. He explores the transformative potential of Organ-on-a-chip (OOC) technology in reshaping preclinical research and highlights a pivotal moment for the industry, where regulatory momentum is accelerating the shift away from animal testing in favour of more human-relevant models. 👉 Discover how CN Bio is leading this change and what the future holds for OOC innovation. 🔗https://bit.ly/4o7m5v2

📣The CN Bioteam is getting ready to for the Safety Pharmacology Society's 2025 Annual Meeting in Utrecht, The Netherlands! Swing by our poster: Assessment of Species-Specific Hepatotoxicity Profiling in Cross-Species MPS Liver Models and join Isavella Georgiades for the poster presentation during two sessions: 🗓️ 14 October 2025, Tuesday 🕙 14:00 -15:00 And again on 🗓️ 15 October 2025, Wednesday 🕙 14:00 -15:00 Lead Scientist Emily Richardson will also be there to discuss all things Organ-on-a-chip, specially how the technology can be applied to your preclinical safety assessment workflows. 👉If you'd like to arrange a proper meeting, give us a shout in the comments, send us a message, or use the link below and get in touch. 🔗https://bit.ly/3VTvdYc #CNBioAt #SPS2025

📈 When you want to scale up without compromising your data quality, the PhysioMimix Sigle Organ Higher-Throughput System is your go to. ✅ Multi-chip plate-based consumables - 6 to 48 chips per plate ✅ Run 1 to 6 plates simultaneously ✅ Screen up to 288 samples per run with the Liver-48 plates PhysioMimix® grows with your research - scalable, cost-effective, multiomics-ready! 👉 Ready to scale your OOC workflow? Discover more: https://bit.ly/4pUz05n

October marks 🌎 International Liver Month, a time to spotlight one of the body’s most resilient yet vulnerable organs. According to the Journal of Hepatology, over 2 million deaths annually are attributed to liver disease, that's 1 in every 25 deaths worldwide! In this new article from Technology Networks, Dr. Sarah Payne from CN Bio, explores how advanced human models and machine learning are transforming liver research, offering hope for earlier detection, better understanding of metabolic disorders, and accelerated drug development. Discover why now is the time to rethink how we study conditions like MASLD, type 2 diabetes, and alcoholic liver disease. Learn how microphysiological systems (MPS) and AI tools can overcome the limitations of traditional preclinical approaches, leading to a smarter and more efficient methods of therapeutic development through a synopsis of published customer insights. 👉Can human-relevant models and AI help reverse the rise in liver disease? Read the full article to find out. 🔗https://bit.ly/4nDc7Sr

🚀 When flexibility is key, the PhysioMimix® Multi-organ System adapts to your evolving research needs: 🔹 Seamlessly transition from single-organ to multi-organ studies 🔹 Gain deeper mechanistic insights into disease states 🔹 Uncover human inter-organ cross talk effects 🔹 Study reactive metabolite-driven and multi-organ toxicity 🔹 Evaluate drug ADME & bioavailability PhysioMimix’s open architecture empowers you to tailor models and assays to your specific context of use. 👉 Ready to go further? Discover more: https://bit.ly/4pSGoxS

📰 Our September Newsletter is live! This month, we dive deep into the industry's pulse. Our CEO and CSO share their perspectives on OOC market momentum and the latest regulatory trends. Are you seeing the same inflection point? Dive into this quick read and let us know your perspective in the comments! 👇 #Newsletter #MonthlyRecap #OrganOnAChip #CNBioAt